Certara, Inc.
CERT US
CERT USCertara, Inc.
United States Composite17.67
USD
+0.37
(+2.14%)
Company Description
- CEO
- Dr. William F. Feehery Ph.D.
- Full Time Employees
- 1,338
- Sector
- Healthcare
- Industry
- Health Information Services
- Address
- 100 Overlook Center Princeton NJ United States 08540
- CIK
- 0001827090
- Website
- www.certara.com
- Business
- Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Company News
Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform
Barclays Remains a Hold on Certara (CERT)
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
Insider Sell: President of Drug Dev Solutions at Certara Inc (CERT) Sells Shares
Maintaining Hold Rating for Certara Amid Balanced Financials and Industry Headwinds
Certara, Inc.'s (NASDAQ:CERT) Intrinsic Value Is Potentially 66% Above Its Share Price
Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?